Cytiva Launches Sefia Platform to Barriers in CAR T Cell

Sefia Cytiva. PCI Pharma Services chooses Cytiva for aseptic filling expansion into In order to operate the Sefia Select module in the way it is intended: • The user must have a general understanding of cell processing, and knowledge The Sefia Select module is intended for research or cellular product manufacturing use

WARNING The single-use kits are sterilized with Ethylene Oxide (EtO) and anaphylactic reactions can occur in hypersensitive people. As part of your cell therapy workflow: Sefia Select™ system automates cell isolation, harvest, and formulation steps; Sefia™ expansion system automates cell activation, transduction, and cell expansion steps

Cytiva Sefia S2000 Cell Harvesting System Etsy

The Sefia S-2000 cell processing instrument is also referred to as the "Sefia instru-ment" throughout this manual Cytiva's Sefia cell therapy manufacturing platform has been designed with these specific challenges in mind In order to operate the Sefia Select module in the way it is intended: • The user must have a general understanding of cell processing, and knowledge

Sefia S2000 Cell Processing instrument Cytiva. An introduction of the new, end-to-end solution from Cytiva to manufacture autologous CAR T therapies at commercial scale Implementation of the Sefia™ platform enables us to increase efficiencies and produce CAR T cell therapies at a global scale."

Security of supply in cell and gene therapy manufacturing Cytiva. Sefia Select module is a new accessory designed specifically to work with Sefia S-2000 instrument; to As the global leader in cell therapy, Kite is proud to be on the forefront of cell therapy automation and to be part of a collaboration with Cytiva that developed the Sefia™ platform